Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048

Liu, AY; Zhang, JY; Anderson, PL; Wagner, T; Pan, ZY; Peda, M; Gomez, K; Beamer, M; Jacobson, C; Strizki, J; Dezzutti, CS; Piper, JM

Liu, AY (reprint author), San Francisco Dept Publ Hlth, Bridge HIV, 25 Van Ness Ave,Ste 100, San Francisco, CA 94102 USA.

CLINICAL INFECTIOUS DISEASES, 2019; 68 (7): 1129